Evidence-Based Treatments for Addiction and Co-Occurring Eating Disorders Treating substance use disorders alongside eating disorders requires an integrated, whole-person model of care
doi:10.1152/ajpendo.00069.2016 Gupta NA, Mells J, Dunham RM, et al
These are the techniques that separate adequate results from optimal results
At 24 weeks, average weight loss was: At 48 weeks, average weight loss was: The study also found that, at 48 weeks, 100% of people taking 12mg lost at least 5% of their body weight , 93% lost at least 10% , and 83% lost at least 15%
Taking a smaller dose than what your doctor recommends isnt a good idea Image content: This image is available to view online
Clinical trial reports and substudy publications describe retatrutide within an obesity trial framework where body weight reduction is the primary endpoint, but appetite and intake driven biology is part of the mechanistic context for why body weight changes occur over time